Australian biotech market today 28.04.09
28 April, 2009 by Kate McDonaldBiota, CSL, Hexima, Alchemia, Mesoblast
Mesoblast fuses Phase II
28 April, 2009 by Kate McDonaldMesoblast approved for Phase II trail for cervical spine fusion
Prima applies for IND
28 April, 2009 by Kate McDonaldPrima BioMed applies for IND for CVac, raises cash
I am the walrus
24 April, 2009 by Kate McDonald“Walking seal” fossil sheds light on land-to-sea transition and pinniped evolution
Australian biotech market today 23.04.09
23 April, 2009 by Kate McDonaldBiota, Circadian, Clinuvel, Cochlear, Pharmaxis, Diversa
Thank you, Darling – UK spends on tech
23 April, 2009 by Kate McDonaldUK taxes rich, spends on tech investment fund
Australian biotech market today 22.04.09
22 April, 2009 by Kate McDonaldGenetic Technologies, Circadian, Bionomics, Ambri, Hexima, LCT, Pharmaxis, Cellestis, AIC
Bionomics targets throat cancer
22 April, 2009 by Kate McDonaldThroat cancer added to list of targets for VDA, Celera developing proteomics-based lung cancer diagnostic
Solid performance for biotech: PwC
21 April, 2009 by Kate McDonaldLatest PwC BioForum report has unexpected good news, but fundamentals are unchanged
Australian biotech market today 21.04.09
21 April, 2009 by Kate McDonaldNeuren, ChemGenex, Novogen, Biota, Alchemia, Impedimed, Sirtex
QRxPharma hits on right dose
20 April, 2009 by Kate McDonaldQRxPharma completes Phase III dose pilot for opioids
Progen targets epigenetics
20 April, 2009 by Kate McDonaldProgen working on polyamine analogues for DNA demethylases, cell proliferation
Fermiscan and Polartechnics to merge
20 April, 2009 by Kate McDonaldTwo Sydney diagnostics company to form Novus Diagnostics
Fight of the honeybees
16 April, 2009 by Kate McDonaldSpanish researchers may have found a cure for honeybee colony collapse disorder
